Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Axovant Sciences Failed To Mention Critical Information [Seeking Alpha]

Axon Enterprise, Inc. (AXON) 
Last axon enterprise, inc. earnings: 2/7 04:15 pm Check Earnings Report
Company Research Source: Seeking Alpha
Summary Axovant Sciences licensed an unproven gene therapy from Benitec Biopharma. Toxicology, histology, and efficacy studies in sheep have not been announced. Axovant's Parkinson's gene therapy, AXO-Lenti-PD, has yet to enter clinical trials. The first generation Parkinson's gene therapy didn't produce meaningful results. Axovant announced a filing to sell $75 million in common shares. On July 10th 2018 Axovant Sciences ( AXON ) announced a partnership with Benitec Biopharma ( BNTC ) for exclusive global rights to BB-301, now named AXO-AAV-OPMD, for the treatment of oculopharyngeal muscular dystrophy, or OPMD, and five additional gene therapy programs in neurological disorders. Benitec will receive an upfront cash payment of $10 million and potentially an additional $17.5 million upon completion of four near-term milestones. Benitec is eligible to earn $187.5 million in total for other milestones, and retain 30% of the net profits on worldwide sales of AXO- Show less Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AXON alerts
Opt-in for
AXON alerts

from News Quantified
Opt-in for
AXON alerts

from News Quantified